Clinical Trials

26 enrolled

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT02346253 2026-04-13

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

146 enrolled

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT02466971 2026-04-13

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

450 enrolled 11 charts

Phase 3 Active not recruiting

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT04214067 2026-04-13

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

164 enrolled

Sarcoma

Carcinosarcoma

NCT03543189 2026-04-01

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

Phase 1/2 Active not recruiting

44 enrolled

Phase 4 Active not recruiting

Prostatic Diseases, Prostatic Neoplasms

NCT04033081 2026-03-23

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

100 enrolled

Sarcoma

NCT00185744 2026-03-20

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

121 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal

NCT00525720 2026-03-09

Brachytherapy for Prostatic Carcinoma Patients

300 enrolled

Prostatic Neoplasms

NCT01946529 2026-02-23

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

24 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT05320406 2026-02-12

REVELUTION

94 enrolled 13 charts

Prostatic Neoplasms

NCT04395079 2026-02-09

Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

9 enrolled

Metastatic Malignant Female Reproductive System Neoplasm

NCT03955978 2026-01-06

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

10 enrolled

Endometrial Neoplasms

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

115 enrolled

Sarcoma

Rhabdomyosarcoma

NCT02595879 2025-11-13

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

21 enrolled 22 charts

Uterine Cervical Neoplasms

NCT05100472 2025-11-04

A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

50 enrolled

Prostatic Neoplasms

NCT04253483 2025-09-17

Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

14 enrolled

Prostatic Neoplasms

NCT01655836 2025-09-11

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

42 enrolled

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT04634877 2025-06-09

KEYNOTE-B21

990 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT05994300 2025-06-08

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

30 enrolled

Uterine Cervical Neoplasms, Radiation Injuries

NCT00769223 2025-03-20

Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer

Active not recruiting

3,561 enrolled

Prostatic Neoplasms, Radiation Injuries

NCT05663294 2025-02-03

PRISCILLA

150 enrolled

Breast

Breast Neoplasms

NCT03277469 2024-10-31

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer

49 enrolled

Gynecologic Cancer

NCT06419673 2024-05-17

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

240 enrolled

Uterine Cervical Neoplasms

NCT01783535 2024-04-16

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma